COVID-19 Resource Page 

CPS is working hard, as we all are, to try to keep up with COVID19 information. Here we have provided some basic links which can take you to more in-depth information at those sites. We also attempt to post information important to pharmacy practice in context of COVID-19 in Colorado. It is in no way a comprehensive list of information, and please know that we cannot confirm it will always be the latest as things change minute to minute.  


If you have suggestions or items you think should be here, please contact us at [email protected]!


COVID-19: Implications for Pharmacists Webinar Series


In partnership with the Colorado Pharmacists Society, the CU Skaggs School of Pharmacy and Pharmaceutical Sciences is offering a free webinar series for pharmacists on the topic of COVID-19. 
We've compiled a page of the webinar recordings, presentation slides, and CE information below. 


Go to Webinar Series 


Community Forum/Blog 

CPS has an open forum for COVID-19 issues/concerns/questions! We add breaking information here as it comes, but any CPS members are welcome to contribute!

To navigate to the Community Forum:

Log in under your membership information →  Member Center→ Community Forum → From the Board Updates “COVID-19 Open Forum for All”

Relief Help

If you are a pharmacist, technician or intern willing to add your name to a registry of willing professionals to pitch in and work, please complete the form below:

Pharmacist Relief Volunteer Form


Note for Professionals Seeking Opportunities to Volunteer or Re-Enter Workforce:

Governor Polis has just announced as a website for those Coloradans hoping to volunteer or assist in the COVID-19 response in a variety of ways. 

When considering whether you want to volunteer or re-enter the healthcare field, or the nature of your service, please be aware of CDC guidelines around high risk populations and exposure to the virus.

 Pharmacist Testing for COVID-19

  • APhA Testing Guidance
               - Practice Info

  • Colorado (DORA): DORA Actions to Implement Governor’s Directive

    In addition to foregoing existing statutory authority for emergency assistance by healthcare professionals, and in light of the Governor’s directive to take action to expand the healthcare workforce so as to address the Disaster Emergency, DORA has identified the following specific statutes and regulations as preventing, hindering, or delaying necessary action in coping with the Disaster Emergency identified in the Governor’s Executive Order 20-003 and which therefore are temporarily suspended pursuant to § 24-33.5-704(7)(a), C.R.S.:

    Suspension of Pharmacy Board Rule 6.00.30, which sets forth the qualifications for pharmacists to engage in drug therapy management and thereby restricts pharmacists from conducting screening tests for the Coronavirus, so as to ensure that pharmacists may conduct screening tests in pharmacies and other testing centers.


  • State Board of Pharmacy Adopts Emergency Rules - Effective 5/1/20 (May 1, 2020)



COVID-19 Medication Information


CO State Information


State Regulatory and Advocacy Issues

Colorado Pharmacists Society – Advocacy and Regulatory Actions


Department of Regulatory Agencies (DORA) / State Board of Pharmacy


National Information

                   Full access:  Username: [email protected]  Password: covid-19



National Regulatory and Advocacy Issues



PBM Information




Hand Sanitizer 


Pharmacist Well-being



Study/Treatment for Exposed Pharmacists or Household Contacts 

There is a COVID-19 post-exposure prophylaxis study out of the University of Minnesota that is open to all healthcare providers nationwide. 
They are seeking research volunteers who have been:
1. Closely exposed to a person with confirmed COVID-19 disease within <= 3 days;        


2. Are a household contact or a healthcare worker;


3. Do not have current symptoms of COVID-19 disease
To enroll, email [email protected]. They will send you an with a link to a screening survey. Prophylaxis regimen will be overnighted to you. The regimen is hydroxychloroquine 800 mg orally once, followed in 6 to 8 hours by 600 mg, then 600 mg once a day for 4 days (5 days total). On day 5 and 14 you will complete an online survey.   

You can contact David Boulware, MD (Twitter @boulware_dr) or Melanie Nicol, PharmD (Twitter @MelanieRNicol) for more information.